99% Semaglutide with manufactory direct supply at wholesale price
12 Inquiries
796043-06-6
Pharmaceutical Grade
99%
Guangzhou
Chunqiao
2mg 5mg 10mg per vial
2026-08-31
peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Peptide
CAS No.:796043-06-6
Molecular Formula:C21H30N2O6S
Molecular Weight:438.54
Categories:
Characteristics-
Density:
1.373±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
Boiling Point:605.408±63.00 °C(Press: 760.00 Torr)(predicted)
PKA:14.773±0.10(predicted)
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptide
-
Location:
Unit 1-B2141, 19B-F1, 81-1 Nonglinxia Road, Yuexiu District, Guangzhou, China
-
Payment Terms:
100% TT in advance
-
Year of Establishment:
2026
-
-
Inquiry History12 Inquiries
Country Product Purchase Quantity Date Posted
United States
Retatrutide 10mg Retatrutide 10mg
10 MT May 16, 2026
United States
Retatrutide 10 mg
10 MG Mar 4, 2026
Hongkong, China
Peptide
10000 MT Jan 6, 2026
United States
Peptide
1 MT Feb 13, 2026
United States
Peptide
100 Jan 28, 2026
United States
Peptide
5 G Oct 3, 2026
United States
Peptide
400 MT Sep 25, 2026
Malaysia
Peptide
100 MG Sep 23, 2026
Greenland
Peptide
10 MG Sep 2, 2026
Ireland
retatrutide 10mg
10 Mar 27, 2026
Canada
Peptide
10 G Mar 1, 2026
Canada
Peptide
1 MT Feb 24, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Cibinetide ARA-290 Peptide Acting On Erythropoietin Receptors For Neuroprotective Research Use
Cosmetics Grade / 99%
$80/MT EXW
-
-
-
-
Semax Hexapeptide Known For Nootropic Effects, Supplied For Behavioral And Cognitive Research
Cosmetics Grade / 99%
$45/UNIT EXW
-
-
-
-
Indazole-3-carboxylic acid CAS 4498-67-3 Off white To Light Yellow Solid Powder Supplier Guangzhou Chunqiao
Cosmetics Grade / 99.9%
$20-24/MT FOB
-
-
-
-
Glucagon Like Peptide Analogue Semaglutide, Manufactured As Freeze Dried Research Grade Material
Cosmetics Grade / 99%
$34/MT EXW
-
-
-
-
GLP-1 High-Grade Research Peptide Lyophilized For Incretin Pharmacology Preclinical Trials
Cosmetics Grade / 99%
$130/MT EXW
-
-
-
-
Pramlintide High-Grade Research Peptide Lyophilized For Glycemic Control Preclinical Research
Cosmetics Grade / 99%
$135/MT EXW
-